{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:06:54Z","timestamp":1761898014428,"version":"3.40.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jad.2024.06.100","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T23:25:45Z","timestamp":1719444345000},"page":"194-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Early improvement with cariprazine as a predictor of antidepressant, anxiolytic, and antimanic response in bipolar I mania and depression: A pooled post hoc analysis of randomized cariprazine trials"],"prefix":"10.1016","volume":"362","author":[{"given":"Mauricio","family":"Tohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huy-Binh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2024.06.100_bb0005","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archpsyc.60.12.1228","article-title":"Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected","volume":"60","author":"Agid","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"year":"2000","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision","author":"APA","key":"10.1016\/j.jad.2024.06.100_bb0010"},{"year":"2013","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"APA","key":"10.1016\/j.jad.2024.06.100_bb0015"},{"key":"10.1016\/j.jad.2024.06.100_bb0025","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/bdi.12099","article-title":"Stage managing bipolar disorder","volume":"16","author":"Berk","year":"2014","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2024.06.100_bb0035","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4088\/JCP.14m09081","article-title":"Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study","volume":"76","author":"Calabrese","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.06.100_bb0040","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1192\/bjp.bp.110.081992","article-title":"Effects of anxiety on the long-term course of depressive disorders","volume":"200","author":"Coryell","year":"2012","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.06.100_bb0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/bdi.12238","article-title":"The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial","volume":"17","author":"Durgam","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2024.06.100_bb0050","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1176\/appi.ajp.2015.15020164","article-title":"An 8-week randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of cariprazine in patients with bipolar I depression","volume":"173","author":"Durgam","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.06.100_bb0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jad.2017.09.040","article-title":"Clinically relevant response and remission outcomes in cariprazine-treated patients with bipolar I disorder","volume":"226","author":"Earley","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.06.100_bb0060","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1176\/appi.ajp.2018.18070824","article-title":"Cariprazine treatment of bipolar depression: a randomized double-blind placebo-controlled phase 3 study","volume":"176","author":"Earley","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.06.100_bb0065","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/bdi.12852","article-title":"Efficacy and safety of cariprazine in bipolar I depression: a double-blind, placebo-controlled phase 3 study","volume":"22","author":"Earley","year":"2020","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2024.06.100_bb0070","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1017\/S0033291704002612","article-title":"Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D","volume":"34","author":"Fava","year":"2004","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2024.06.100_bb0075","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2024.06.100_bb0080","unstructured":"Guy, W., 1976. The Clinical Global Impression Severity and Improvement Scales. ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education and Welfare publication (ADM). 76-338. Rockville, MD: 218\u2013222 (National Institute of Mental Health; 1976)."},{"key":"10.1016\/j.jad.2024.06.100_bb0085","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.jad.2024.06.100_bb0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2024.06.100_bb0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jpsychires.2010.05.016","article-title":"Early symptom change and prediction of subsequent remission with olanzapine augmentation in divalproex-resistant bipolar mixed episodes","volume":"45","author":"Houston","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2024.06.100_bb0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/YIC.0000000000000500","article-title":"Efficacy of cariprazine in patients with bipolar depression and higher or lower levels of baseline anxiety: a pooled post hoc analysis","volume":"39","author":"Jain","year":"2024","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2024.06.100_bb0105","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1176\/appi.ajp.162.5.939","article-title":"Evidence for onset of antipsychotic effects within the first 24 hours of treatment","volume":"162","author":"Kapur","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.06.100_bb0110","first-page":"5","article-title":"Predictive value of early improvement in bipolar depression trials: a post-hoc pooled analysis of two 8-week aripiprazole studies","volume":"43","author":"Kemp","year":"2010","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2024.06.100_bb0115","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jad.2010.10.026","article-title":"Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression","volume":"130","author":"Kemp","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.06.100_bb0120","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.4088\/JCP.09m05874yel","article-title":"Clinical utility of early improvement to predict response or remission in acute mania: focus on olanzapine and risperidone","volume":"72","author":"Kemp","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.06.100_bb0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jpsychires.2009.07.006","article-title":"Rapid antipsychotic response with ziprasidone predicts subsequent acute manic\/mixed episode remission","volume":"44","author":"Ketter","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2024.06.100_bb0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jad.2021.12.027","article-title":"Baseline anxiety, and early anxiety\/depression improvement in anxious depression predicts treatment outcomes with escitalopram: a CAN-BIND-1 study report","volume":"300","author":"Khoo","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.06.100_bb0135","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.schres.2008.02.021","article-title":"Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia","volume":"102","author":"Kinon","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2024.06.100_bb0140","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/npp.2009.164","article-title":"Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia","volume":"35","author":"Kinon","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2024.06.100_bb0150","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.biopsych.2005.02.023","article-title":"Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended","volume":"57","author":"Leucht","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.jad.2024.06.100_bb0160","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0165-0327(14)70003-5","article-title":"The prevalence and burden of bipolar depression","volume":"169","author":"Miller","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.06.100_bb0165","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.06.100_bb0175","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jad.2014.11.018","article-title":"Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial","volume":"174","author":"Sachs","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.06.100_bb0180","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jad.2008.10.005","article-title":"Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety","volume":"115","author":"Sheehan","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.06.100_bb0190","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4088\/JCP.v64n0410","article-title":"Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression","volume":"64","author":"Szegedi","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.06.100_bb0195","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4088\/JCP.07m03780","article-title":"Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients","volume":"70","author":"Szegedi","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2024.06.100_bb0200","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jad.2013.01.024","article-title":"Early improvement as a predictor of acute treatment outcome in manic or mixed episodes in bipolar-1 disorder: a pooled, post hoc analysis from the asenapine development program","volume":"150","author":"Szegedi","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.06.100_bb0205","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1001\/archpsyc.1990.01810240026005","article-title":"Outcome in mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis","volume":"47","author":"Tohen","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2024.06.100_bb0210","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1034\/j.1399-5618.2000.20307.x","article-title":"Onset of action of antipsychotics in the treatment of mania","volume":"2","author":"Tohen","year":"2000","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2024.06.100_bb0220","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.eurpsy.2009.11.012","article-title":"Predicting the course and outcome of bipolar disorder: a review","volume":"25","author":"Treuer","year":"2010","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2024.06.100_bb0225","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12640-010-9197-8","article-title":"Staging bipolar disorder","volume":"19","author":"Vieta","year":"2011","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.jad.2024.06.100_bb0230","volume":"4","author":"Vieta","year":"2018","journal-title":"Bipolar disorders. Nat Rev Dis Primers."},{"key":"10.1016\/j.jad.2024.06.100_bb0240","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2024.06.100_bb0245","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724010309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724010309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T16:51:55Z","timestamp":1742230315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032724010309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":41,"alternative-id":["S0165032724010309"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2024.06.100","relation":{},"ISSN":["0165-0327"],"issn-type":[{"type":"print","value":"0165-0327"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early improvement with cariprazine as a predictor of antidepressant, anxiolytic, and antimanic response in bipolar I mania and depression: A pooled post hoc analysis of randomized cariprazine trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2024.06.100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AbbVie Inc. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}